Deep Tide TechFlow News, November 22, according to PR Newswire, Nasdaq-listed biotechnology company Anixa Biosciences (NASDAQ: ANIX) announced that the board has approved the inclusion of Bitcoin in the company's treasury reserve assets. The company's CEO Amit Kumar stated that this move is part of prudent financial management aimed at creating greater value for shareholders.

Anixa President and CFO Mike Catelani pointed out that with the approval of Bitcoin ETFs and increased institutional investor participation, Bitcoin has become a mainstream asset class. He emphasized that Bitcoin's unique anti-inflation characteristics and potential for value storage align with the company's pursuit of long-term financial stability and growth.